Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Have there been sustained impacts of the COVID-19 pandemic on trends in smoking prevalence, uptake, quitting, use of treatment, and relapse? A monthly population study in England, 2017–2022

Fig. 3

Use of support by smokers in quit attempts, overall and by social grade. Panels show trends in the prevalence of use of A prescription medication, B behavioural support, and C e-cigarettes in the most recent quit attempt among past-year smokers who made a least one quit attempt (unweighted n: overall = 5754, ABC1 = 2908, C2DE = 2846), June 2017 to August 2022. Lines represent modelled weighted prevalence over the study period, adjusted for covariates. Points represent unadjusted weighted prevalence by month. The vertical dashed line indicates the timing of the start of the COVID-19 pandemic in England (March 2020). Corresponding data without adjustment for dependence are shown in Additional File 5: Fig. 2 and Additional File 5: Table 4. ABC1, managerial/professional/intermediate; C2DE, small employers/lower supervisory/technical/semi-routine/routine/never workers/long-term unemployed

Back to article page